Published in Cancer Weekly, March 30th, 2004
According to scientists in Germany, "New conditioning regimens are being explored to reduce toxicity and enable allogeneic bone marrow transplantation in patients not eligible for conventional transplantation."
"A series of 30 patients who were not eligible for standard conditioning therapy received transplants from HLA-matched related...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.